Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomic approaches to hematologic malignancies.

Benjamin L Ebert1, Todd R Golub

  • 1Dana Farber Cancer Institute, D640, 44 Binney St, Boston, MA 02115, USA.

Blood
|May 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Journal of the American Chemical Society·2026
Same author

<i>Ppm1d</i> Clonal Hematopoiesis Does Not Promote Atherosclerosis in Murine Models.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Clonal hematopoiesis in lung adenocarcinoma pathogenesis.

JCI insight·2026
Same author

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

Blood·2026
Same author

Charged molecular glue discovery enabled by targeted degron display.

Nature chemical biology·2026
Same author

Endogenous aldehydes: A driver of clonal hematopoiesis from within?

Cell stem cell·2026

DNA microarrays refine the molecular understanding of blood cancers, identifying new subclasses and therapeutic targets. Ongoing research addresses challenges in data interpretation for improved diagnostics and treatments.

Area of Science:

  • Hematology
  • Genomics
  • Molecular Biology

Background:

  • DNA microarrays have significantly advanced the molecular classification of hematologic malignancies.
  • Gene expression profiling reveals molecular abnormalities, oncologic phenotypes, and clinical outcomes.

Purpose of the Study:

  • To review the current state of discovery in molecular taxonomy of hematologic malignancies using DNA microarrays.
  • To highlight novel subclasses, therapeutic targets, and future research directions.

Main Methods:

  • Utilizing DNA microarray technology for genome-wide gene expression surveys.
  • Analyzing large datasets to identify molecular profiles and patterns.

Main Results:

  • Characterization of molecular profiles for known diagnostic classifications.

Related Experiment Videos

  • Identification of novel subclasses with distinct molecular and clinical behaviors.
  • Highlighting specific cellular pathways for targeted therapy.

    • Conclusions:

    • Microarray findings are integrating into clinical practice for diagnostics and clinical trials.
    • Challenges in statistical interpretation and biologic validation of gene expression data persist.
    • Genomic technologies promise deeper insights into the molecular circuitry of hematologic malignancies.